Rhonda M Cooper-DeHoff
Overview
Explore the profile of Rhonda M Cooper-DeHoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
215
Citations
4813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu Y, Keeley E, Barrette E, Cooper-DeHoff R, Dhruva S, Gaffney J, et al.
BMC Cardiovasc Disord
. 2024 Sep;
24(1):497.
PMID: 39289597
Background: Improving hypertension control is a public health priority. However, consistent identification of uncontrolled hypertension using computable definitions in electronic health records (EHR) across health systems remains uncertain. Methods: In...
2.
Cicali E, Eddy E, Gong Y, Elchynski A, Pena Del Aguila K, Basha T, et al.
Clin Transl Sci
. 2024 Jul;
17(7):e13890.
PMID: 39046302
The University of Florida Health conducted a pragmatic implementation of a pharmacogenetics (PGx) panel-based test to guide medications used for supportive care prescribed to patients undergoing chemotherapy. The implementation was...
3.
Mehanna M, McDonough C, Smith S, Gong Y, Gums J, Chapman A, et al.
Clin Transl Sci
. 2024 May;
17(5):e13816.
PMID: 38747311
Hypertensive patients with a higher proportion of genetic West African ancestry (%GWAA) have better blood pressure (BP) response to thiazide diuretics (TDs) and worse response to β-blockers (BBs) than those...
4.
Holmes H, Li Q, Xu K, Kim S, Richards E, Keeley E, et al.
Am Heart J Plus
. 2024 Apr;
5:100023.
PMID: 38560412
Introduction: Antihypertensive medication nonadherence is a prevalent issue but is very difficult to accurately assess. To clarify this problem among hypertensive patients attending a cardiovascular disease outpatient clinic, we utilized...
5.
Lu Y, Keeley E, Barrette E, Cooper-DeHoff R, Dhruva S, Gaffney J, et al.
Res Sq
. 2024 Feb;
PMID: 38410433
Background: Improving hypertension control is a public health priority. However, consistent identification of uncontrolled hypertension using computable definitions in electronic health records (EHR) across health systems remains uncertain. Methods: In...
6.
Chekka L, Tantawy M, Langaee T, Wang D, Renne R, Chapman A, et al.
J Am Heart Assoc
. 2024 Feb;
13(4):e032433.
PMID: 38353215
Background: Thiazide diuretics are the second most frequently prescribed class of antihypertensives, but up to 50% of patients with hypertension have minimal antihypertensive response to thiazides. We explored circulating microRNAs...
7.
Smith K, Keshwani S, Walsh M, Winterstein A, Gurka M, Libby A, et al.
Hypertension
. 2024 Jan;
81(2):e7-e9.
PMID: 38232142
No abstract available.
8.
Jafari E, Cooper-DeHoff R, Effron M, Hogan W, McDonough C
Am J Hypertens
. 2023 Sep;
37(1):60-68.
PMID: 37712350
Background: Apparent treatment-resistant hypertension (aTRH) is defined as uncontrolled blood pressure (BP) despite using ≥3 antihypertensive classes or controlled BP while using ≥4 antihypertensive classes. Patients with aTRH have a...
9.
Lu Y, Keeley E, Barrette E, Cooper-DeHoff R, Dhruva S, Gaffney J, et al.
medRxiv
. 2023 Aug;
PMID: 37546792
Background: Improving hypertension control is a public health priority. However, uncertainty remains regarding the optimal way to identify patients with uncontrolled hypertension using electronic health records (EHR) data. Methods: In...
10.
Chamberlain A, Cooper-DeHoff R, Pletcher M
Mayo Clin Proc
. 2023 Jun;
98(6):949.
PMID: 37270276
No abstract available.